Tarsus Pharmaceuticals, Inc. (TARS)
74.53
-0.48
(-0.64%)
USD |
NASDAQ |
Feb 25, 09:35
Tarsus Pharmaceuticals Profit Margin (Quarterly) : -5.52% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -5.33% |
| Precigen, Inc. | -5.01K% |
| Celcuity, Inc. | -- |
| Mirum Pharmaceuticals, Inc. | 2.18% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.04% |
| Return on Assets | -13.42% |
| Return on Invested Capital | -16.94% |
| Gross Profit Margin (Quarterly) | 92.80% |
| Operating Margin (Quarterly) | -5.26% |
| Return on Net Operating Assets | -64.61% |